Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul 25:12:1448789.
doi: 10.3389/fcell.2024.1448789. eCollection 2024.

Zinc finger proteins: guardians of genome stability

Affiliations
Review

Zinc finger proteins: guardians of genome stability

Zeeba Kamaliyan et al. Front Cell Dev Biol. .

Abstract

Zinc finger proteins (ZNF), a unique yet diverse group of proteins, play pivotal roles in fundamental cellular mechanisms including transcription regulation, chromatin remodeling, protein/RNA homeostasis, and DNA repair. Consequently, the mis regulation of ZNF proteins can result in a variety of human diseases, ranging from neurodevelopmental disorders to several cancers. Considering the promising results of DNA damage repair (DDR) inhibition in the clinic, as a therapeutic strategy for patients with homologous recombination (HR) deficiency, identifying other potential targetable DDR proteins as emerged vulnerabilities in resistant tumor cells is essential, especially when considering the burden of acquired drug resistance. Importantly, there are a growing number of studies identifying new ZNFs and revealing their significance in several DDR pathways, highlighting their great potential as new targets for DDR-inhibition therapy. Although, there are still many uncharacterized ZNF-containing proteins with unknown biological function. In this review, we highlight the major classes and observed biological functions of ZNF proteins in mammalian cells. We briefly introduce well-known and newly discovered ZNFs and describe their molecular roles and contributions to human health and disease, especially cancer. Finally, we discuss the significance of ZNFs in DNA repair mechanisms, their potential in cancer therapy and advances in exploiting ZNF proteins as future therapeutic targets for human disease.

Keywords: DNA repair; cancer; genome integrity; human disease; zinc finger (ZNF).

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Classification of zinc finger proteins and their cellular functions. This figure demonstrates major classes of zinc finger proteins, characterized protein examples of each group, and their involvement in cellular and molecular mechanisms.
FIGURE 2
FIGURE 2
Schematic representation of different human phenotypes associated with mis-regulation of zinc-finger proteins. This figure represents reported human diseases and deficiencies associated with zinc-finger protein mis-regulation.

References

    1. Adeyemo A. A., Zaghloul N. A., Chen G., Doumatey A. P., Leitch C. C., Hostelley T. L., et al. (2019). ZRANB3 is an African-specific type 2 diabetes locus associated with beta-cell mass and insulin response. Nat. Commun. 10, 3195. 10.1038/s41467-019-10967-7 - DOI - PMC - PubMed
    1. Ahel I., Ahel D., Matsusaka T., Clark A. J., Pines J., Boulton S. J., et al. (2008). Poly (ADP-ribose)-binding zinc finger motifs in DNA repair/checkpoint proteins. Nature 451, 81–85. 10.1038/nature06420 - DOI - PubMed
    1. Aravind L., Iyer L. M., Koonin E. V. (2003). Scores of RINGS but no PHDs in ubiquitin signaling. Cell. Cycle 2, 123–126. 10.4161/cc.2.2.335 - DOI - PubMed
    1. Bardia A., Sun S., Thimmiah N., Coates J. T., Wu B., Abelman R. O., et al. (2024). Antibody drug conjugate sacituzumab govitecan enables a sequential TOP1/PARP inhibitor cancer therapy strategy in breast cancer patients. Clin. Cancer Res. 10.1158/1078-0432.CCR-24-0428 - DOI - PMC - PubMed
    1. Baxter J. S., Zatreanu D., Pettitt S. J., Lord C. J. (2022). Resistance to DNA repair inhibitors in cancer. Mol. Oncol. 16, 3811–3827. 10.1002/1878-0261.13224 - DOI - PMC - PubMed

LinkOut - more resources